Jake Bauer

Jake Bauer is an accomplished professional in the biotech and pharmaceutical sectors, serving as a Member of the Board of Directors at multiple organizations, including Attralus, Immunovant, and Enliven Therapeutics. Previously, they held key positions such as Principal at Third Rock Ventures and Chief Business Officer at MyoKardia. Jake has extensive experience in business operations and corporate development, having worked at Ablexis, LLC and Royalty Pharma. They obtained an MBA from Harvard Business School in 2007 and continue to contribute as a Venture Partner at ARCH Venture Partners and SR One Capital Management.